A Systematic Review of How To Reduce Morbidity in HIV Patients With Cardiovascular Diseases

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Human immunodeficiency virus (HIV) infection is linked to a higher incidence of cardiovascular diseases, including atherosclerosis and cardiomyopathy.
• Multiple factors contribute to cardiovascular disease risk in the HIV population, such as malnutrition, vitamin deficiencies, substance abuse, and viral effects.
• Cardiovascular diseases represent a significant cause of morbidity and mortality in HIV-infected individuals, impacting global healthcare costs.

Purpose of the Study:

• To investigate the multifaceted factors contributing to coronary artery disease and other cardiovascular diseases in the context of HIV infection.
• To analyze the direct and indirect impacts of HIV on cardiovascular health.
• To evaluate the role of antiretroviral therapy (ART) in exacerbating cardiovascular disease risk.

Main Methods:

• Review and synthesis of existing research on HIV and cardiovascular disease.
• Assessment of etiological factors, including lifestyle, nutritional status, and viral load.
• Analysis of the association between antiretroviral therapy regimens and cardiovascular outcomes.

Main Results:

• HIV infection exerts both direct and indirect detrimental effects on the development of coronary artery diseases.
• Antiretroviral therapy, while crucial for HIV management, can further increase the risk of cardiovascular diseases.
• Identified research gaps in understanding the complex causal relationships and associations.

Conclusions:

• Current management strategies for cardiovascular diseases in HIV patients are acknowledged.
• Emphasizes the critical need for developing future prevention strategies tailored to individual patient needs.
• Highlights the importance of considering clinical and socio-economic backgrounds when tailoring treatment regimens.